Lipid Metabolism Practice Questions

Q: Glycerol is the backbone of all of the following phospholipids EXCEPT?

Sphingomyelin. ### Explanation The core concept tested here is the structural classification of phospholipids. Phospholipids are divided into two main categories based on their alcohol backbone: **Glycerophospholipids** (glycerol backbone) and **Sphingophospholipids** (sphingosine backbone). **Why Sphingomyelin is the Correct Answer:** Sphingomyelin is the only human phospholipid that is **not** a glycerophospholipid. Instead of glycerol, it contains **sphingosine**, an 18-carbon amino alcohol. A fatty acid is attached to the amino group of sphingosine to form a **ceramide**, and a phosphorylcholine group is attached to the primary hydroxyl group. Therefore, it lacks a glycerol backbone. **Analysis of Incorrect Options:** * **A & C (Phosphatidylethanolamine & Phosphatidylcholine):** These are the most abundant glycerophospholipids in cell membranes. They consist of a glycerol-3-phosphate backbone esterified with two fatty acids and a nitrogenous base (ethanolamine or choline). * **B (Cardiolipin):** Also known as diphosphatidylglycerol, it consists of two molecules of phosphatidic acid linked by a **glycerol** bridge. It is unique to the inner mitochondrial membrane. **NEET-PG High-Yield Pearls:** * **Sphingomyelinase Deficiency:** Leads to **Niemann-Pick Disease**, characterized by hepatosplenomegaly and "cherry-red spots" on the macula. * **Cardiolipin Clinical Link:** It is the antigen used in the **VDRL test** for Syphilis. Antibodies against it (Anti-cardiolipin antibodies) are seen in **Antiphospholipid Syndrome (APS)**. * **Dipalmitoylphosphatidylcholine (DPPC):** Also known as Lecithin, it is the major constituent of **lung surfactant**. A Lecithin/Sphingomyelin (L/S) ratio > 2 in amniotic fluid indicates fetal lung maturity.

Q: Prostaglandins are derived from:

Arachidonic acid. **Explanation:** Prostaglandins belong to a group of biologically active lipid compounds called **Eicosanoids** (20-carbon fatty acids). They are synthesized from **Arachidonic acid**, a polyunsaturated fatty acid (PUFA) containing 20 carbons and four double bonds (C20:4, ω-6). 1. **Why Arachidonic acid is correct:** Arachidonic acid is released from membrane phospholipids by the enzyme **Phospholipase A₂**. It then enters the **Cyclooxygenase (COX) pathway** to produce Prostaglandins, Prostacyclins, and Thromboxanes, or the **Lipoxygenase (LOX) pathway** to produce Leukotrienes. 2. **Why other options are incorrect:** * **Stearic acid:** A 18-carbon saturated fatty acid (C18:0). It does not have the double bonds or carbon length required for eicosanoid synthesis. * **Glutamic acid & Aspartic acid:** These are acidic amino acids involved in protein synthesis and the urea cycle, not lipid metabolism or prostaglandin synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The release of arachidonic acid by **Phospholipase A₂** is the rate-limiting step in prostaglandin synthesis. This enzyme is inhibited by **Corticosteroids** (via Annexin A1/Lipocortin). * **NSAIDs Mechanism:** Aspirin and other NSAIDs act by irreversibly or reversibly inhibiting **COX-1 and COX-2**, thereby blocking prostaglandin synthesis. * **Essential Fatty Acid Link:** Arachidonic acid is considered semi-essential; it can be synthesized from the essential fatty acid **Linoleic acid** (C18:2, ω-6). * **Prostaglandin E1 (Alprostadil):** Used clinically to keep the Ductus Arteriosus patent in neonates with cyanotic heart disease.

Q: A young man presents for a physical exam concerned about his family history of premature heart attacks. His father died of a heart attack in his late 40s. The patient has elevated serum cholesterol and LDL levels, with normal VLDL and triglycerides. Further investigation reveals an LDL receptor deficiency. Which type of hyperlipidemia does this patient have?

Type IIa. **Explanation:** The patient presents with a classic case of **Familial Hypercholesterolemia (Type IIa Hyperlipoproteinemia)**. This condition is characterized by a genetic deficiency or defect in the **LDL receptors**, leading to impaired clearance of LDL from the plasma. **Why Type IIa is correct:** In Type IIa, there is a selective elevation of **Low-Density Lipoprotein (LDL)**. Since LDL is the primary carrier of cholesterol, the lipid profile shows significantly elevated serum cholesterol with **normal triglycerides and VLDL**. The clinical history of premature coronary artery disease (CAD) and autosomal dominant inheritance (suggested by the father’s early death) are hallmark features. **Why other options are incorrect:** * **Type I (Familial Chylomicronemia):** Caused by a deficiency in Lipoprotein Lipase (LPL) or Apo C-II. It presents with severely elevated **Triglycerides** and Chylomicrons, not isolated cholesterol. * **Type IIb (Combined Hyperlipidemia):** Involves elevation of both **LDL and VLDL**. Consequently, both cholesterol and triglycerides are elevated, unlike this patient who has normal VLDL/Triglycerides. * **Type III (Dysbetalipoproteinemia):** Caused by **Apo E deficiency**, leading to the accumulation of IDL and Chylomicron remnants (Broad-beta band). Both cholesterol and triglycerides are typically elevated. **High-Yield NEET-PG Pearls:** * **Clinical Signs:** Look for **Xanthomas** (Tendon xanthoma is pathognomonic for Type II) and **Corneal arcus** at a young age. * **Friedewald Formula:** LDL = Total Cholesterol – [HDL + (TG/5)]. Note: This is invalid if TG >400 mg/dL. * **Statins** are the first-line treatment as they upregulate LDL receptor expression.

Q: Beta-oxidation of fatty acids occurring in peroxisomes is differentiated from that occurring in mitochondria by which of the following?

Formation of H2O2. **Explanation:** The primary difference between mitochondrial and peroxisomal beta-oxidation lies in the **initial step of the pathway**, specifically how electrons are transferred from the substrate. 1. **Why Option B is Correct:** In mitochondria, the first step is catalyzed by *Acyl-CoA dehydrogenase*, which transfers electrons to FAD, eventually entering the electron transport chain to produce ATP. In **peroxisomes**, the first step is catalyzed by **Acyl-CoA oxidase**. This enzyme transfers electrons directly to molecular oxygen ($O_2$), resulting in the formation of **Hydrogen Peroxide ($H_2O_2$)**. This $H_2O_2$ is subsequently degraded by the enzyme **catalase**. 2. **Why Other Options are Incorrect:** * **Option A:** Both pathways result in the production of **Acetyl CoA** (though peroxisomal oxidation stops at shorter chain lengths, usually octanoyl-CoA, which is then exported to mitochondria). * **Option C:** While it is true that different enzymes are used (e.g., bifunctional protein in peroxisomes), the question asks for the specific biochemical product that *differentiates* the two processes. $H_2O_2$ formation is the hallmark metabolic distinction. * **Option D:** Both pathways require $NAD^+$ and produce **NADH** during the 3-hydroxyacyl-CoA dehydrogenase step. **High-Yield NEET-PG Pearls:** * **Substrate Specificity:** Peroxisomes are specialized for the oxidation of **Very Long Chain Fatty Acids (VLCFA)** (C22 or longer) and branched-chain fatty acids (e.g., phytanic acid via alpha-oxidation). * **Energy Yield:** Peroxisomal oxidation is **less energy-efficient** because the first step bypasses the ETC, dissipating energy as heat rather than capturing it as ATP. * **Clinical Correlation:** Defects in peroxisomal beta-oxidation or biogenesis lead to **Zellweger Syndrome** (accumulation of VLCFA in the brain and liver) and **X-linked Adrenoleukodystrophy**.

Q: What is the number of double bonds in arachidonic acid?

4. **Explanation:** Arachidonic acid is a **20-carbon** polyunsaturated fatty acid (PUFA) belonging to the **Omega-6 (ω-6)** family. Its chemical notation is **20:4 (Δ5, 8, 11, 14)**, which indicates that it contains **4 double bonds** located at the 5th, 8th, 11th, and 14th carbon atoms. **Why Option D is Correct:** Arachidonic acid is synthesized from the essential fatty acid, linoleic acid. It serves as the primary precursor for the synthesis of **eicosanoids**, including prostaglandins, thromboxanes, and leukotrienes, via the cyclooxygenase (COX) and lipoxygenase (LOX) pathways. **Why Other Options are Incorrect:** * **Option A (1):** Represents monounsaturated fatty acids (MUFA) like **Oleic acid** (18:1). * **Option B (2):** Represents **Linoleic acid** (18:2), an essential ω-6 fatty acid. * **Option C (3):** Represents **α-Linolenic acid** (18:3), an essential ω-3 fatty acid. **High-Yield NEET-PG Pearls:** 1. **Essentiality:** Arachidonic acid becomes "essential" only if its precursor, linoleic acid, is deficient in the diet. 2. **Pro-inflammatory role:** Most eicosanoids derived from arachidonic acid (like PGE2 and LTB4) are mediators of inflammation. 3. **Membrane source:** It is typically esterified in membrane phospholipids at the **sn-2 position** and is released by the enzyme **Phospholipase A2**. 4. **Mnemonic:** Remember the "4" in the name "Arachidonic" (A-R-A-C) to recall the 4 double bonds.

Q: What is the only part of an odd-chain fatty acid that is glucogenic?

Propionyl CoA. **Explanation:** In the metabolism of fatty acids, even-chain fatty acids undergo β-oxidation to produce **Acetyl CoA**, which enters the TCA cycle but cannot be used for net glucose synthesis (gluconeogenesis) because the two carbons lost as $CO_2$ in the cycle balance the two carbons entering. **Why Propionyl CoA is correct:** Odd-chain fatty acids undergo β-oxidation until a final three-carbon fragment remains: **Propionyl CoA**. This is the only part of the fatty acid that is glucogenic because it follows a specific three-step pathway: 1. **Propionyl CoA** is carboxylated to D-methylmalonyl CoA (requires **Biotin/B7**). 2. It is isomerized to L-methylmalonyl CoA. 3. L-methylmalonyl CoA is converted to **Succinyl CoA** (requires **Vitamin B12**). Succinyl CoA is a TCA cycle intermediate that can be converted to oxaloacetate and subsequently enter the gluconeogenic pathway to form glucose. **Why the other options are incorrect:** * **B. Acetyl CoA:** Produced by even-chain fatty acids; it cannot be converted back to pyruvate or oxaloacetate for net glucose synthesis in humans. * **C. Malonyl CoA:** An intermediate in fatty acid *synthesis* (lipogenesis) and a potent inhibitor of Carnitine Palmitoyltransferase-1 (CPT-1); it is not a product of β-oxidation. * **D. Acyl CoA:** This is a general term for a fatty acid attached to Coenzyme A at any stage of oxidation; it is not a specific glucogenic end-product. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin B12 Deficiency:** Leads to the accumulation of **Methylmalonic acid (MMA)** in urine, a specific diagnostic marker that distinguishes B12 deficiency from Folate deficiency. * **Enzyme Deficiency:** Propionic acidemia is caused by a deficiency of Propionyl CoA carboxylase. * **Mnemonic:** "Odd-chain fatty acids are the exception to the rule that fats don't make sugar."

Q: What is the common precursor of mineralocorticoids, glucocorticoids, and sex steroids?

Pregnenolone. **Explanation:** The synthesis of all steroid hormones (steroidogenesis) begins with **cholesterol**. The first and rate-limiting step occurs in the mitochondria, where the enzyme **Cholesterol side-chain cleavage enzyme (P450scc/Desmolase)** converts cholesterol into **Pregnenolone**. Pregnenolone serves as the "master precursor" or the common trunk of the steroidogenic pathway. From Pregnenolone, the pathway branches out to produce: 1. **Mineralocorticoids** (e.g., Aldosterone) via Progesterone. 2. **Glucocorticoids** (e.g., Cortisol) via 17-hydroxypregnenolone. 3. **Sex Steroids** (e.g., Testosterone, Estrogen) via Dehydroepiandrosterone (DHEA). **Analysis of Incorrect Options:** * **B. 17-alpha-hydroxyprogesterone:** This is an intermediate specifically involved in the synthesis of glucocorticoids and sex steroids, but it is formed *after* pregnenolone. * **C. Dehydrotestosterone (DHT):** This is a potent androgen derived from testosterone via the action of 5-alpha-reductase; it is a terminal product, not a common precursor. * **D. 11-Deoxycortisol:** This is a direct precursor to cortisol in the glucocorticoid pathway, formed by the action of 21-hydroxylase. **High-Yield NEET-PG Pearls:** * **Rate-limiting step:** Conversion of Cholesterol to Pregnenolone by **Desmolase**. This step is stimulated by ACTH in the adrenal cortex and LH in the gonads. * **StAR Protein:** The Steroidogenic Acute Regulatory (StAR) protein is responsible for transporting cholesterol into the mitochondria; its deficiency leads to Congenital Lipoid Adrenal Hyperplasia. * **Congenital Adrenal Hyperplasia (CAH):** The most common enzyme deficiency is **21-hydroxylase**, which leads to a buildup of 17-hydroxyprogesterone and shunting of precursors toward androgen synthesis (virilization).

Q: Which enzyme is deficient in Refsum disease?

Phytanoyl-CoA a-hydroxylase. **Explanation:** **Refsum Disease** is a rare autosomal recessive peroxisomal disorder characterized by the inability to degrade **phytanic acid**, a 20-carbon branched-chain fatty acid derived from chlorophyll in the diet. 1. **Why Option B is Correct:** Phytanic acid has a methyl group at the beta-carbon, which blocks normal $\beta$-oxidation. To bypass this, the body uses **$\alpha$-oxidation** to remove the first carbon atom as $CO_2$. The key enzyme for this process is **Phytanoyl-CoA $\alpha$-hydroxylase (PhyH)**. In Refsum disease, a deficiency of this enzyme leads to the toxic accumulation of phytanic acid in tissues and plasma, particularly affecting the nervous system and retina. 2. **Why Other Options are Incorrect:** * **A. Sphingomyelinase:** Deficient in **Niemann-Pick disease**, leading to sphingomyelin accumulation. * **C. Alpha-galactosidase A:** Deficient in **Fabry disease**, an X-linked lysosomal storage disorder. * **D. N-acetylglucosaminidase:** Deficient in **Sanfilippo syndrome Type B** (a Mucopolysaccharidosis). **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** Retinitis pigmentosa, peripheral neuropathy, and cerebellar ataxia. Other features include sensorineural deafness and ichthyosis (scaly skin). * **Diagnosis:** Elevated serum levels of phytanic acid. * **Management:** Dietary restriction of chlorophyll-containing foods (e.g., green leafy vegetables, dairy, and ruminant fats). * **Zellweger Syndrome vs. Refsum:** While both involve peroxisomes, Zellweger is a defect in peroxisome *biogenesis*, whereas Refsum is a specific enzyme defect in $\alpha$-oxidation.

Q: What is the main component of surfactant?

Dipalmitoyl phosphatidylcholine. **Explanation:** **1. Why Dipalmitoyl phosphatidylcholine (DPPC) is correct:** Lung surfactant is a complex mixture of lipids and proteins, but it is composed of approximately **90% lipids**. The most abundant and functionally significant lipid (accounting for ~50-60% of total surfactant) is **Dipalmitoyl phosphatidylcholine (DPPC)**, also known as **Lecithin**. * **Mechanism:** DPPC is an amphipathic molecule. Its hydrophobic fatty acid tails point toward the air, while the hydrophilic head points toward the alveolar water layer. This orientation significantly **reduces surface tension** at the air-liquid interface, preventing alveolar collapse (atelectasis) during expiration. **2. Why the other options are incorrect:** * **Phosphatidylinositol:** While present in surfactant, it is a minor component (approx. 5-10%) and does not play the primary role in reducing surface tension. * **Dipalmitoyl cephalin (Phosphatidylethanolamine):** Cephalin is a major component of cell membranes (especially nervous tissue) but is not the primary constituent of surfactant. * **Dipalmitoyl serine:** Phosphatidylserine is involved in cell signaling and apoptosis (flipping to the outer membrane leaflet), but it is not a major component of lung surfactant. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **L/S Ratio:** Fetal lung maturity is assessed by the **Lecithin/Sphingomyelin ratio** in amniotic fluid. A ratio **>2.0** indicates mature lungs. * **Type II Pneumocytes:** Surfactant is synthesized and secreted by Type II alveolar cells and stored in **Lamellar bodies**. * **NRDS:** Deficiency of surfactant in premature infants leads to **Neonatal Respiratory Distress Syndrome (Hyaline Membrane Disease)**. * **Glucocorticoids:** These are administered to mothers in preterm labor to stimulate surfactant production by inducing enzymes like *cholinephosphotransferase*.

Q: Which leukodystrophy is characterized by the inability to properly catabolize very-long-chain fatty acids (VLCFA) within peroxisomes, leading to elevated levels of VLCFA in serum?

Adrenoleukodystrophy. **Explanation:** **Adrenoleukodystrophy (ALD)** is an X-linked recessive disorder caused by a mutation in the **ABCD1 gene**, which encodes a peroxisomal membrane transporter protein. This defect prevents the entry of **Very-Long-Chain Fatty Acids (VLCFA)** into the peroxisome for **beta-oxidation**. Consequently, VLCFAs accumulate in the serum and tissues, particularly the adrenal cortex and the white matter of the CNS, leading to demyelination and adrenal insufficiency (Addison’s disease). **Analysis of Incorrect Options:** * **Metachromatic Leukodystrophy:** Caused by a deficiency of **Arylsulfatase A**, leading to the accumulation of **sulfatides**. It is characterized by "metachromasia" of nerves when stained with toluidine blue. * **Krabbe Disease (Globoid Cell Leukodystrophy):** Caused by a deficiency of **Galactocerebrosidase**, leading to the accumulation of galactocerebroside and psychosine. Histology shows characteristic multinucleated **globoid cells**. * **Ortho Leukodystrophy:** A general term for leukodystrophies with normal myelin breakdown products (like Pelizaeus-Merzbacher disease), but it is not specifically associated with VLCFA metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Peroxisomal Disorders:** ALD is the most common peroxisomal disorder. Another high-yield condition is **Zellweger Syndrome** (generalized peroxisome biogenesis defect), which also shows elevated VLCFAs but presents with more severe craniofacial dysmorphism and hepatomegaly. * **Clinical Triad of ALD:** Behavioral changes/cognitive decline, vision/hearing loss, and adrenal failure. * **Biochemical Marker:** Elevated **C24:0 and C26:0** fatty acids in plasma.

Question 1

Glycerol is the backbone of all of the following phospholipids EXCEPT?

Accepted Answer

Sphingomyelin

Answer

Phosphatidylethanolamine

Answer

Cardiolipin

Answer

Phosphatidylcholine

Question 2

Prostaglandins are derived from:

Accepted Answer

Arachidonic acid

Answer

Stearic acid

Answer

Glutamic acid

Answer

Aspartic acid

Question 3

A young man presents for a physical exam concerned about his family history of premature heart attacks. His father died of a heart attack in his late 40s. The patient has elevated serum cholesterol and LDL levels, with normal VLDL and triglycerides. Further investigation reveals an LDL receptor deficiency. Which type of hyperlipidemia does this patient have?

Accepted Answer

Type IIa

Answer

Type I

Answer

Type IIb

Answer

Type III

Question 4

Beta-oxidation of fatty acids occurring in peroxisomes is differentiated from that occurring in mitochondria by which of the following?

Accepted Answer

Formation of H2O2

Answer

Formation of Acetyl CoA

Answer

Presence of different enzymes in different sites

Answer

Requirement of NADH

Question 5

What is the number of double bonds in arachidonic acid?

Accepted Answer

4

Answer

1

Answer

2

Answer

3

Question 6

What is the only part of an odd-chain fatty acid that is glucogenic?

Accepted Answer

Propionyl CoA

Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Acyl CoA

Question 7

What is the common precursor of mineralocorticoids, glucocorticoids, and sex steroids?

Accepted Answer

Pregnenolone

Answer

alpha-hydroxyprogesterone

Answer

Dehydrotestosterone

Answer

Deoxycortisol

Question 8

Which enzyme is deficient in Refsum disease?

Accepted Answer

Phytanoyl-CoA a-hydroxylase

Answer

Sphingomyelinase

Answer

Alpha galactosidase-A

Answer

N-acetylglucosaminidase

Question 9

What is the main component of surfactant?

Accepted Answer

Dipalmitoyl phosphatidylcholine

Answer

Phosphatidylinositol

Answer

Dipalmitoyl cephalin

Answer

Dipalmitoyl serine

Question 10

Which leukodystrophy is characterized by the inability to properly catabolize very-long-chain fatty acids (VLCFA) within peroxisomes, leading to elevated levels of VLCFA in serum?

Accepted Answer

Adrenoleukodystrophy

Answer

Ortho leukodystrophy

Answer

Metachromatic leukodystrophy

Answer

Krabbe disease

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?